The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...
Addyi (flibanserin) was cleared a decade ago to treat low sex drive in women before menopause. A new FDA action allows ...
Pregnancy, menopause and hormone therapy may all impact a woman’s lipoprotein(a) level, challenging the mantra of the once-in ...
An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.
On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...
The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...
U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by women older than 65.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback